Abstract:Mitochondria, pivotal organelles crucial for energy generation, apoptosis regulation, and cellular metabolism, have spurred remarkable advancements in targeted material development. This review surveys recent breakthroughs in targeted mitochondrial nanomaterials, illuminating their potential in drug delivery, disease management, and biomedical imaging. This review approaches from various application perspectives, introducing the specific applications of mitochondria-targeted materials in cancer treatment, probes and imaging, and diseases treated with mitochondria as a therapeutic target. Addressing extant challenges and elucidating potential therapeutic mechanisms, it also outlines future development trajectories and obstacles. By comprehensively exploring the diverse applications of targeted mitochondrial nanomaterials, this review aims to catalyze innovative treatment modalities and diagnostic approaches in medical research. STATEMENT OF SIGNIFICANCE: This review presents the latest advancements in mitochondria-targeted nanomaterials for biomedical applications, covering diverse fields such as cancer therapy, bioprobes, imaging, and the treatment of various systemic diseases. The novelty and significance of this work lie in its systematic analysis of the intricate relationship between mitochondria and different diseases, as well as the ingenious design strategies employed to harness the therapeutic potential of nanomaterials. By providing crucial insights into the development of mitochondria-targeted nanomaterials and their applications, this review offers a valuable resource for researchers working on innovative treatment modalities and diagnostic approaches. The scientific impact and interest to the readership lie in the identification of promising avenues for future research and the potential for clinical translation of these cutting-edge technologies.

Mitochondria-Targeted Antioxidants: A Step towards Disease Treatment

The Mitochondrion-Targeted Antioxidants in Kidney Disease

Molecular strategies for targeting antioxidants to mitochondria: therapeutic implications.

[Mitochondrial therapy: a new strategy for treating mitochondrion-associated diseases]

Nanozymes targeting mitochondrial repair in disease treatment

Mitochondria-Targeted Drugs

Mitochondrial targeted strategies and their application for cancer and other diseases treatment

Unraveling mitochondria‐targeting reactive oxygen species modulation and their implementations in cancer therapy by nanomaterials

Mitochondrial dysfunction-targeted nanosystems for precise tumor therapeutics

Mitochondrial dysfunction: mechanisms and advances in therapy

Targeted Mitochondrial Nanomaterials in Biomedicine: Advances in Therapeutic Strategies and Imaging Modalities

Targeting Cancer Cell Mitochondria As a Therapeutic Approach.

Recent advances in mitochondria-targeting theranostic agents

Targeted mitochondrial delivery: A therapeutic new era for disease treatment

Mitochondrial transplantation: A promising therapy for mitochondrial disorders

Targeting mitochondrial quality control: new therapeutic strategies for major diseases

Mitochondria-targeting drug conjugates for cytotoxic, anti-oxidizing and sensing purposes: current strategies and future perspectives

The Role of Mitochondria in Cellular Toxicity As a Potential Drug Target

Mitochondrial Dysfunction in Cardiovascular Diseases: Potential Targets for Treatment

Therapeutic Targeting of the Mitochondria Initiates Excessive Superoxide Production and Mitochondrial Depolarization Causing Decreased mtDNA Integrity

Targeting mitochondrial reactive oxygen species as novel therapy for inflammatory diseases and cancers